Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for ...

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis.

Through this agreement, Xcellbio scientists will work with the Royal Perth Hospital team to develop an automated TIL manufacturing process based on AVATAR platform that achieves key goals for cell ...

Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades.

People who have used prescription-strength Tretinoin say the over-the-counter cream has given them the same results they had ...

ConferenceHeidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 26.03.2025 / 09:23 CET/CESTThe issuer is solely responsible for the content of this ...

“Preclinical findings illuminate the superior GSTP1 binding affinity and inhibitory potency of this novel prodrug ... improved specificity towards cancer cells relative to normal cells and ...

Affiliate content. Discover the top 10 best mushroom supplements for 2025 to boost immunity, enhance brain function, and support overall wellness.